Regional variation on the presentation of Alzheimer's disease patients in memory clinics within Europe: Data from the ICTUS study

Journal of Alzheimer's Disease

Volumn 21, Issue 1, 2010, Pages 155-165

  Hausner, Lucrezia ^a,b   Frölich, Lutz ^a   Gardette, Virginie ^b   Reynish, Emma ^b,c   Ousset, Pierre Jean ^b   Andrieu, Sandrine ^b   Vellas, Bruno ^b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b TOULOUSE UNIVERSITY HOSPITAL   (France)

^c ROYAL EDINBURGH HOSPITAL   (United Kingdom)

Author keywords

Alzheimer's disease; clinical course; cross sectional data; dementia; drug usage; Europe; multi centre study; observational study

Indexed keywords

PSYCHOTROPIC AGENT;

AGED; ALZHEIMER DISEASE; ARTICLE; CAREGIVER BURDEN; COGNITIVE DEFECT; COMORBIDITY; DISEASE SEVERITY; EDUCATIONAL STATUS; EUROPE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; OUTPATIENT DEPARTMENT; PRIORITY JOURNAL; PSYCHOSOCIAL CARE; WORLD HEALTH ORGANIZATION; ADULT; CAREGIVER; CULTURAL FACTOR; LONGITUDINAL STUDY; MEMORY DISORDERS; MENTAL HEALTH; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; PSYCHOLOGY; SELF CONCEPT; TOPOGRAPHY; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; CAREGIVERS; CROSS-CULTURAL COMPARISON; EUROPE; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MEMORY DISORDERS; MENTAL STATUS SCHEDULE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; SELF CONCEPT; TOPOGRAPHY, MEDICAL; YOUNG ADULT;

EID: 77955004287     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2010-091489     Document Type: Article

References (47)

1. Christensen K, Doblhammer G, Rau R, Vaupel JW (2009) Ageing populations: the challenges ahead. Lancet 374, 11961208.
2. Hanyu H, Sato T, Hirao K, Kanetaka H, Sakurai H, Iwamoto T (2009) Differences in clinical course between dementia with Lewy bodies and Alzheimer's disease. Eur J Neurol 16, 212217.
3. Bruandet A, Richard F, Bombois S, Maurage CA, Derame-court V, Lebert F, Amouyel P, Pasquier F (2009) Alzheimer disease with cerebrovascular disease and vascular dementia: clinical features and course compared with Alzheimer disease. J Neurol Neurosurg Psychiatry 80, 133-139.
4. Bidzan L, Pachalska M, Grochmal-Bach B, Bidzan M, Jastrzebowska G (2008) Behavioral and psychological symptoms and the progression of dementia of the Alzheimer type in nursing home residents. Med Sci Monit 14, CR559-567.
5. Matthews FE, Stephan BC, McKeith IG, Bond J, Brayne C (2008) Medical Research Council Cognitive Function and Ageing Study: Two-year progression from mild cognitive impairment to dementia: to what extent do different definitions agree? J Am Geriatr Soc 56, 1424-1433.
6. Steenland K, MacNeil J, Vega I, Levey A (2009) Recent trends in Alzheimer disease mortality in the United States, 1999 to 2004. Alzheimer Dis Assoc Disord 23, 165-170.
7. Mauskopf JA, Paramore C, Lee WC, Snyder EH (2005) Drug persistency patterns for patients treated with rivastigmine or donepezil in usual care settings. J Manag Care Pharm 11, 231-251.
8. Herrmann N, Gill SS, Bell CM, Anderson GM, Bronskill SE, Shulman KI, Fischer HD, Sykora K, Shi HS, Rochon PA (2007) A population-based study of cholinesterase inhibitor use for dementia. J Am Geriatr Soc 55, 1517-1523.
9. Sicras-Mainar A, Vergara J, Leon-Colombo T, Febrer L, Rejas-Gutierrez J (2006) Retrospective comparative analysis of antidementia medication persistence patterns in Spanish Alzheimer's disease patients treated with donepezil, rivastig-mine, galantamine and memantine. Rev Neurol 43, 449-453.
10. Frolich L, Andreasen N, Tsolaki M, Foucher A, Kavanagh S, Van Baelen B, Schwalen S (2009) Long-term treatment of patients with Alzheimers disease in primary and secondary care: results from an international survey. Curr Med Res Opin 25, 3059-3068.
11. Oude Voshaar RC, Burns A, Olde Rikkert MG; European Dementia Consensus Network Group (EDCON) (2006) Alarming arbitrariness in EU prescription and reimbursement criteria for anti-dementia drugs. Int J Geriatr Psychiatry 21, 29-31.
12. Purandare N, Swarbrick C, Fischer A, Burns A (2006) Cholinesterase inhibitors for Alzheimer's disease: variations in clinical practice in the north-west of England. Int J Geriatr Psychiatry 21, 961-964.
13. Cohen-Mansfield J, Parpura-Gill A (2008) Practice style in the nursing home: dimensions for assessment and quality improvement. Int J Geriatr Psychiatry 23, 376-386.
14. Cohen-Mansfield J, Mintzer JE (2005) Time for change: the role of nonpharmacological interventions in treating behavior problems in nursing home residents with dementia. Alzheimer Dis Assoc Disord 19, 37-40.
15. Camp CJ, Cohen-Mansfield J, Capezuti EA (2002) Use of non-pharmacologic interventions among nursing home residents with dementia. Psychiatr Serv 53, 1397-1401.
16. Bank AL, Argiielles S, Rubert M, Eisdorfer C, Czaja SJ (2006) The value of telephone support groups among ethnically diverse caregivers of persons with dementia. Gerontologist 46, 134-138.
17. Wood W, Harris S, Snider M, Patchel SA (2005) Activity situations on an Alzheimer's disease special care unit and resident environmental interactions, time use, and affect. Am J Alzheimers Dis Other Demen 20, 105-118.
18. Olde Rikkert MGM, Lauque S, Frolich L, Vellas B, Dekkers W (2005) The practice of obtaining approval from medical research ethics committees: A comparison within 12 European countries for a descriptive study on acetylcholinesterase inhibitors in Alzheimer dementia. Eur J Neurol 12, 212-217.
19. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services TaskForce on Alzheimer's Disease. Neurology 34, 939-944.
20. Rosen WG, Mohs RC, Davis KL (1984) A new rating scale for Alzheimer's disease. Am J Psychiatry 141, 1356-1364.
21. Folstein MF, Folstein SE, McHugh PR (1975) 'Minimental state': a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12, 189-198.
22. Morris JC (1993) The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology 43, 2412-2414.
23. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services TaskForce on Alzheimer's Disease. Neurology 34, 939-944.
24. Katz S, Ford AB, Moskowitz RW, Jackson BA, Jaffe MW (1963) Studies of illness in the aged. The Index of ADL: a standardized measure ofbiological and psychosocial function. JAMA 185, 914-919.
25. Lawton MP, Brody EM (1969) Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist 9, 179-186.
26. Cummings JL, Mega M, Gray K, Rosenberg-Thompson S, Carusi DA, Gornbein J (1994) The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology 44, 2308-2314.
27. Zarit SH, Todd PA, Zarit JM (1986) Subjective burden of husbands and wives as caregivers: a longitudinal study. Geron-tologist 26, 260-266.
28. Reynish E, Cortes F, Andrieu S, Cantet C, Olde Rikkert M, Melis R, Froelich L, Frisoni GB, Jonsson L, Visser PJ, Ousset PJ, Vellas B; ICTUS Study Group (2007) The ICTUS Study: A Prospective longitudinal observational study of 1,380 AD patients in Europe. Study design and baseline characteristics of the cohort. Neuroepidemiology 29, 29-38.
29. World Population Prospects (2004) The 2004 Revision, CD-ROM Edition (United Nations publication, Basic Dataset, Sales No. E.05.XIII.10; Comprehensive Dataset, Sales No. E.05.XIII.11; Extended Dataset, Sales No. E.05.XIII.12). page xiii
30. Wimo A, Winblad B, Jonsson L (2007) An estimate of the total worldwide societal costs of dementia in 2005. Alzheimers Dement 3, 81-91.
31. Bolin K, Lindgren B, Lundborg P (2008) Informal and formal care among single-living elderly in Europe. Health Econ 17, 393-409.
32. Jtjnsson L, Wimo A (2009) The cost of dementia in Europe: a review of the evidence, and methodological considerations. Pharmacoeconomics 27, 391-403.
33. Wimo A, Wetterholm AL, Mastey V, Winblad B (1998) Evaluation ofthe healthcare resource utilization and caregiver time in anti-dementia drug trials: a quantitative battery. In Health Economics of Dementia, Wimo A, Jonsson B, Karlsson G, Winblad B, eds. Wiley, Chichester, pp. 465-499.
34. National Institutes of Health (1998) Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults-The evidence report. Obes Res 6(Suppl 2), 51S-209S.
35. Crum RM, Anthony JC, Bassett SS, Folstein MF (1993) Population-based norms for the Mini-Mental State Examination by age and educational level. JAMA 269, 2386-2391.
36. Andel R, Vigen C, Mack WJ, Clark LJ, Gatz M (2006) The effect of education and occupational complexity on rate of cognitive decline in Alzheimer's patients. J Int Neuropsychol Soc 12, 147-152.
37. Fritsch T, McClendon MJ, Smyth KA, Ogrocki PK (2002) Effects of educational attainment and occupational status on cognitive and functional decline in persons with Alzheimer-type dementia. Int Psychogeriatr 14, 347-363.
38. Scarmeas N, Albert SM, Manly JJ, Stern Y (2006) Education and rates ofcognitive decline in incident Alzheimer's disease. J Neurol Neurosurg Psychiatry 77, 308-316.
39. Stern Y (2009) Cognitive reserve. Neuropsychologia 47, 20152028.
40. Brodaty H, Donkin M (2009) Family caregivers of people with dementia. Dialogues Clin Neurosci 11, 217-228.
41. Carpenter GI (2005) Aging in the United Kingdom and Europe-a snapshot of the future? J Am Geriatr Soc 53(Suppl 9), S310-S313.
42. Zunzunegui MV, Beland F, Llacer A, Keller I (1999) Family, religion, and depressive symptoms in caregivers of disabled elderly. J Epidemiol Community Health 53, 364-369.
43. Navaie-Waliser M, Feldman PH, Gould DA, Levine C, Kuerbis AN, Donelan K (2001) The experiences and challenges of informal caregivers: common themes and differences among whites, blacks, and hispanics. Gerontologist 41, 733-741.
44. Waldemar G, Dubois B, Emre M, Georges J, McKeith I G, Rossor M, Scheltens P, Tariska P, Winblad B (2007) Recommendations for the diagnosis and management ofAlzheimer's disease and other disorders associated with dementia: EFNS guideline. Eur J Neurol 14, e1-e26.
45. Adelman AM, Mehr DR (2008) New guideline for the treatment of dementia: is there really anything new? Am Fam Physician 77, 1080-1081.
46. Fuh JL, Mega MS, Binetti G, Wang SJ, Magni E, Cummings JL (2002) A transcultural study of agitation in dementia. J Geriatr Psychiatry Neurol 15, 171-174.
47. Binetti G, Mega MS, Magni E, Padovani A, Rozzini L, Bianchetti A, Trabucchi M, Cummings JL (1998) Behavioral disorders in Alzheimer disease: a transcultural perspective. Arch Neurol 55, 539-544.